Drug Maker Pays $360 Million to Settle Investigation Into Charity Kickbacks
The drug maker Actelion Pharmaceuticals has agreed to a $360 million settlement stemming from an investigation into whether the company illegally funneled kickbacks through a patient-assistance charity, federal prosecutors said Thursday. Actelion, which was acquired by Johnson & Johnson in 2017 and makes expensive drugs to treat a rare lung condition, is the latest pharmaceutical […]